Tumor Growth and Metastasis

作者: Jerry Ware , Shashank Jain

DOI: 10.1016/B978-0-12-387837-3.00038-9

关键词:

摘要: The platelet/tumor cell interaction points to another example supporting the multi-functional properties of platelet. Long recognized as central players in hemostasis and thrombosis, platelets can be essentially hijacked participate a wide range pathological events tumor growth spread cells. platelet particularly advantageous storing cytokines factors that normally support fundamental role wound repair. However, cancer setting these same angiogenesis giving distinct advantage cell. Decades effort understand biology thrombosis has positioned studies provide key mechanistic insights biology. In addition, this work is identifying previously untested therapeutic targets for management tumorigenesis malignancy. Ultimately, outcomes from efforts may improve prognosis patient.

参考文章(74)
E. Gorelik, R. H. Wiltrout, K. Okumura, S. Habu, R. B. Herberman, Role of NK cells in the control of metastatic spread and growth of tumor cells in mice International Journal of Cancer. ,vol. 30, pp. 107- 112 ,(1982) , 10.1002/IJC.2910300118
Jeffrey Kamykowski, Peter Carlton, Siddharth Sehgal, Brian Storrie, Quantitative immunofluorescence mapping reveals little functional coclustering of proteins within platelet α-granules Blood. ,vol. 118, pp. 1370- 1373 ,(2011) , 10.1182/BLOOD-2011-01-330910
Youya Nakazawa, Shigeo Sato, Mikihiko Naito, Yukinari Kato, Kazuhiko Mishima, Hiroyuki Arai, Takashi Tsuruo, Naoya Fujita, Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood. ,vol. 112, pp. 1730- 1739 ,(2008) , 10.1182/BLOOD-2007-11-124693
Joshua I Greenberg, David A Cheresh, VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy Expert Opinion on Biological Therapy. ,vol. 9, pp. 1347- 1356 ,(2009) , 10.1517/14712590903208883
William F. Sindelar, Tommie Sue Tralka, Alfred S. Ketcham, Electron microscopic observations on formation of pulmonary metastases. Journal of Surgical Research. ,vol. 18, pp. 137- 161 ,(1975) , 10.1016/0022-4804(75)90010-4
A. Amirkhosravi, M. Amaya, H. Desai, J. L. Francis, Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity. Blood Coagulation & Fibrinolysis. ,vol. 13, pp. 505- 512 ,(2002) , 10.1097/00001721-200209000-00005
S. Jain, M. Zuka, J. Liu, S. Russell, J. Dent, J. A. Guerrero, J. Forsyth, B. Maruszak, T. K. Gartner, B. Felding-Habermann, J. Ware, Platelet glycoprotein Ibα supports experimental lung metastasis Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 9024- 9028 ,(2007) , 10.1073/PNAS.0700625104
G. J. Gasic, T. B. Gasic, C. C. Stewart, Antimetastatic effects associated with platelet reduction Proceedings of the National Academy of Sciences of the United States of America. ,vol. 61, pp. 46- 52 ,(1968) , 10.1073/PNAS.61.1.46
Mark L. Kahn, Mayumi Nakanishi-Matsui, Michael J. Shapiro, Hiroaki Ishihara, Shaun R. Coughlin, Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin Journal of Clinical Investigation. ,vol. 103, pp. 879- 887 ,(1999) , 10.1172/JCI6042
Rachel E. Tilley, Todd Holscher, Rajesh Belani, Jorge Nieva, Nigel Mackman, Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients Thrombosis Research. ,vol. 122, pp. 604- 609 ,(2008) , 10.1016/J.THROMRES.2007.12.023